Monovalent SARS-COV-2 mRNA vaccine using optimal UTRs and LNPs is highly immunogenic and broadly protective against Omicron variants
Zhongfeng Ye(Tufts University), Qiaobing Xu(Tufts University), Chutian Xu(Tufts University), Li‐Han Liu(Guangdong Pharmaceutical University), Changfeng Huang(Tufts University), Lindsay G. A. McKay(Boston University), Jianzhu Chen(Massachusetts Institute of Technology), Anthony Griffiths(Boston University), Joseph F. Harmon(Tufts University), Z Zhang(Tufts University), Jordyn Walker(The University of Texas Medical Branch at Galveston), Donghui Song(Tufts University), Shuliang Gao(Tufts University), Haitao Hu(Northwest A&F University), Yamin Li(Tufts University), Yu Zhao(Sichuan University), Jinjin Chen(Sichuan University), Kenneth S. Plante(World Health Organization - Pakistan), Srinivasa Reddy Bonam(Indian Institute of Chemical Biology), Jessica A. Plante(The University of Texas Medical Branch at Galveston)
Cited by 26
Related Papers
New Approaches to Nanofabrication: Molding, Printing, and Other Techniques
|Chemical Reviews|2005|2k
Lysosomes as a therapeutic target
|Nature Reviews Drug Discovery|2019|751
Preparation of Monodisperse Biodegradable Polymer Microparticles Using a Microfluidic Flow‐Focusing Device for Controlled Drug Delivery
|Small|2009|588
Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
|Nature|2017|547
Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis
|Proceedings of the National Academy of Sciences|2022|495